Results 281 to 290 of about 156,017 (326)

What should constitute a control condition in psychedelic drug trials? [PDF]

Nat Ment Health
Colloca L, Fava M.
europepmc   +1 more source

Addressing blinding in classic psychedelic studies with innovative active placebos. [PDF]

Int J Neuropsychopharmacol
Aday JS, Simonsson O, Schindler EAD, D'Souza DC.   +3 more
europepmc   +1 more source

Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis. [PDF]

Curr Oncol
Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE.   +6 more
europepmc   +1 more source

The Programmed Placebo Effect in Patients with Syncope: Preliminary Clinical and Nanostructural Insights with a Hypothetical Quantum-Level Interpretation. [PDF]

J Clin Med
Hadžić B, Romčević N, Marković N, Petrović M, Bojić M, Milovanović B.   +5 more
europepmc   +1 more source

Social pain: A systematic review on interventions. [PDF]

F1000Res
Brooks BM, Cordero FJ, Alchermes SL, Brooks BM.   +3 more
europepmc   +1 more source

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Choice over placebo administration enhances open-label placebo hypoalgesia

Pain, 2023
Abstract Many studies indicate that deceptively administered placebos can improve pain outcomes. However, the deception involved presents an ethical barrier to translation because it violates informed consent and patient autonomy. Open-label placebos (OLPs), inert treatments that are openly administered as placebos, have been proposed as an ...
Biya Tang, Evan Livesey, Ben Colagiuri
openaire   +3 more sources

Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial

Pain, 2021
Abstract It is commonly believed that blinding to treatment assignment is necessary for placebos to have an effect. However, placebos administered without concealment (ie, open-label placebos [OLPs]) have recently been shown to be effective in some conditions.
Anthony, Lembo, John M, Kelley, Judy, Nee, Sarah, Ballou, Johanna, Iturrino, Vivian, Cheng, Vikram, Rangan, Jesse, Katon, William, Hirsch, Irving, Kirsch, Kathryn, Hall, Roger B, Davis, Ted J, Kaptchuk   +12 more
openaire   +3 more sources

Deceptive but not open label placebos attenuate motion-induced nausea

Journal of Psychosomatic Research, 2019
Nausea is a common complaint, known to respond to the placebo effect. Existing research has employed deception when administering placebos for nausea, limiting therapeutic translation on ethical grounds. We therefore examined the potential of non-deceptive open-label placebos (OLPs) to reduce nausea.Galvanic Vestibular Stimulation (GVS) and Virtual ...
K, Barnes, A, Yu, J, Josupeit, B, Colagiuri   +3 more
openaire   +3 more sources